Document Detail


Beneficial effect of magnesium on the isolated perfused rat heart during reperfusion after ischaemia: comparison between pre-ischaemic and post-ischaemic administration of magnesium.
MedLine Citation:
PMID:  2402298     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of high concentration of magnesium on both mechanical dysfunction and metabolic damage after ischaemia-reperfusion was studied in isolated rat hearts. The heart was perfused by the Langendorff's technique at a constant flow (10 ml/min) with modified Krebs-Henseleit solution and driven at 300 beats/min. The heart was made ischaemic by reducing the flow to 0 ml/min for 25 min, and then reperfused at the constant flow for 15 min. MgSO4 was added to the perfusate for 5 min before the onset of ischaemia, or after the end of ischaemia (after the onset of reperfusion). Ischaemia-reperfusion produced both mechanical dysfunction (as evidenced by an increase in the left ventricular end diastolic pressure and a decrease in the left ventricular developed pressure) and metabolic damage [as evidenced by a decrease in the myocardial adenosine triphosphate (ATP)]. When 15 mmol/l MgSO4 was given before ischaemia, there was no appreciable recovery of mechanical function, whereas when given after ischaemia (during reperfusion), there was a marked recovery of mechanical function. Lower concentrations (10 or 5 mmol/l) of MgSO4 given after ischaemia recovered the mechanical function concentration-dependently. The beneficial effect of 15 mmol/l MgSO4 was minimized by the coexistence of 4.5 mmol/l CaCl2 in the reperfusion solution. The decrease in the myocardial level of ATP induced by ischaemia-reperfusion was attenuated by 15 mmol/l MgSO4 given in the reperfusion solution. These results suggest that high Mg2+ is effective in attenuating both functional and metabolic damage of the post-ischaemic heart, provided it is given after ischaemia.
Authors:
A Hara; H Matsumura; Y Abiko
Related Documents :
17117228 - Melatonin prevents cardioprotection induced by a multi-cycle ischaemic preconditioning ...
12034058 - Long-term thyroxine administration protects the heart in a pattern similar to ischemic ...
22872268 - Complex craniosynostoses: a review of the prominent clinical features and the related m...
3278168 - Oxygen-derived free radical scavengers for amelioration of reperfusion damage in heart ...
3886568 - Fixed ratio combination of propranolol and bendrofluazide in the treatment of hypertens...
6797998 - Measurement of respiratory gas exchange during artificial respiration.
Publication Detail:
Type:  Comparative Study; In Vitro; Journal Article    
Journal Detail:
Title:  Naunyn-Schmiedeberg's archives of pharmacology     Volume:  342     ISSN:  0028-1298     ISO Abbreviation:  Naunyn Schmiedebergs Arch. Pharmacol.     Publication Date:  1990 Jul 
Date Detail:
Created Date:  1990-10-23     Completed Date:  1990-10-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0326264     Medline TA:  Naunyn Schmiedebergs Arch Pharmacol     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  100-6     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, Asahikawa Medical College, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine Triphosphate / pharmacology
Animals
Blood Pressure / drug effects
Coronary Disease / drug therapy*,  physiopathology
Energy Metabolism / drug effects
Heart / drug effects*
Heart Function Tests
Magnesium / therapeutic use*
Male
Myocardial Reperfusion
Myocardium / metabolism
Phosphocreatine / pharmacology
Rats
Rats, Inbred Strains
Chemical
Reg. No./Substance:
56-65-5/Adenosine Triphosphate; 67-07-2/Phosphocreatine; 7439-95-4/Magnesium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Supersensitivity to intrathecal 5-hydroxytryptamine, but not noradrenaline, following depletion of s...
Next Document:  Positive coupling of cholinergic muscarinic receptors to adenylate cyclase activity in membranes of ...